Literature DB >> 10708864

Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties.

J Vendrell1, E Querol, F X Avilés.   

Abstract

Among the different aspects of recent progress in the field of metallocarboxypeptidases has been the elucidation of the three dimensional structures of the pro-segments (in monomeric or oligomeric species) and their role in the expression, folding and inhibition/activation of the pancreatic and pancreatic-like forms. Also of great significance has been the cloning and characterization of several new regulatory carboxypeptidases, enzymes that are related with important functions in protein and peptide processing and that show significant structural differences among them and also with the digestive ones. Many regulatory carboxypeptidases lack a pro-region, unlike the digestive forms or others in between from the evolutionary point of view. Finally, important advances have been made on the finding and characterization of new protein inhibitors of metallocarboxypeptidases, some of them with interesting potential applications in the biotechnological/biomedical fields. These advances are analyzed here and compared with the earlier observations in this field, which was first explored by Hans Neurath and collaborators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708864     DOI: 10.1016/s0167-4838(99)00280-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  NMR solution structure of the activation domain of human procarboxypeptidase A2.

Authors:  M Angeles Jiménez; Virtudes Villegas; Jorge Santoro; Luis Serrano; Josep Vendrell; Francesc X Avilés; Manuel Rico
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Variants in pancreatic carboxypeptidase genes CPA2 and CPB1 are not associated with chronic pancreatitis.

Authors:  Eriko Nakano; Andrea Geisz; Atsushi Masamune; Tetsuya Niihori; Shin Hamada; Kiyoshi Kume; Yoichi Kakuta; Yoko Aoki; Yoichi Matsubara; Karolin Ebert; Maren Ludwig; Markus Braun; David A Groneberg; Tooru Shimosegawa; Miklós Sahin-Tóth; Heiko Witt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-27       Impact factor: 4.052

3.  Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

Authors:  Mercy O Quagraine; Fulong Tan; Hironori Tamei; Ervin G Erdös; Randal A Skidgel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2.

Authors:  Richárd Szmola; Melinda Bence; Andrea Carpentieri; András Szabó; Catherine E Costello; John Samuelson; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

5.  Variants in CPA1 are strongly associated with early onset chronic pancreatitis.

Authors:  Heiko Witt; Sebastian Beer; Jonas Rosendahl; Jian-Min Chen; Giriraj Ratan Chandak; Atsushi Masamune; Melinda Bence; Richárd Szmola; Grzegorz Oracz; Milan Macek; Eesh Bhatia; Sandra Steigenberger; Denise Lasher; Florence Bühler; Catherine Delaporte; Johanna Tebbing; Maren Ludwig; Claudia Pilsak; Karolin Saum; Peter Bugert; Emmanuelle Masson; Sumit Paliwal; Seema Bhaskar; Agnieszka Sobczynska-Tomaszewska; Daniel Bak; Ivan Balascak; Gourdas Choudhuri; D Nageshwar Reddy; G Venkat Rao; Varghese Thomas; Kiyoshi Kume; Eriko Nakano; Yoichi Kakuta; Tooru Shimosegawa; Lukasz Durko; András Szabó; Andrea Schnúr; Péter Hegyi; Zoltán Rakonczay; Roland Pfützer; Alexander Schneider; David Alexander Groneberg; Markus Braun; Hartmut Schmidt; Ulrike Witt; Helmut Friess; Hana Algül; Olfert Landt; Markus Schuelke; Renate Krüger; Bertram Wiedenmann; Frank Schmidt; Klaus-Peter Zimmer; Peter Kovacs; Michael Stumvoll; Matthias Blüher; Thomas Müller; Andreas Janecke; Niels Teich; Robert Grützmann; Hans-Ulrich Schulz; Joachim Mössner; Volker Keim; Matthias Löhr; Claude Férec; Miklós Sahin-Tóth
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

6.  Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2.

Authors:  András Szabó; Claudia Pilsak; Melinda Bence; Heiko Witt; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

7.  Proenzyme structure and activation of astacin metallopeptidase.

Authors:  Tibisay Guevara; Irene Yiallouros; Reinhild Kappelhoff; Steffen Bissdorf; Walter Stöcker; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

8.  Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from Porphyromonas gingivalis, a causative agent of gum disease from the human oral microbiome.

Authors:  Anja Pomowski; Isabel Usón; Zuzanna Nowakowska; Florian Veillard; Maryta N Sztukowska; Tibisay Guevara; Theodoros Goulas; Danuta Mizgalska; Magdalena Nowak; Barbara Potempa; James A Huntington; Jan Potempa; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

9.  Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite.

Authors:  Laura Sanglas; Francesc X Aviles; Robert Huber; F Xavier Gomis-Rüth; Joan L Arolas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

10.  Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection.

Authors:  James R Hair; Paul A Lyons; Kenneth G C Smith; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.